Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Valeant Pharmaceuticals Intl (VRX)

22.07 -0.07 (-0.32%)

05-21 16:00

Open:

22.43

Pre. Close:

22.14

High:

22.59

Low:

21.94

Volume:

4,726,397

Market Cap:

7709M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

22.623 - 22.737

22.737 - 22.831

Low:

21.679 - 21.798

21.798 - 21.897

Close:

21.895 - 22.082

22.082 - 22.236

Technical analysis  (as of: 2018-05-21 4:34:44 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 26.39     One year: 30.82

Support:

Support1: 19.08    Support2: 16.91

Resistance:

Resistance1: 22.59    Resistance2: 26.39

Pivot:

20.12

Moving Averages:

MA(5): 21.98     MA(20): 19.54

MA(100): 18.53     MA(250): 16.45

MACD:

MACD(12,26): 1.34     Signal(12,26,9): 1.07

%K %D:

%K(14,3): 93.63     %D(3): 94.29

RSI:

RSI(14): 81.02

52-Week:

High: 24.43  Low: 10.94  Change(%): 65.8

Average Vol(K):

3-Month: 996114  10-Days 1489810

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
VRX has closed below upper band by 20.2%. Bollinger Bands are 72.2% wider than normal. The large width of the bands suggest high volatility as compared to VRX's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

2018-05-21T08:18:06-04:00
Progenics Pharmaceuticals: Elucidating The Upcoming Regulatory Binary For Azedra

2018-05-21T01:08:38-04:00
Valeant Pharmaceuticals: Worth At Least $30

2018-05-21T00:30:51-04:00
Valeant: Much Ado About Nothing

2018-05-18T14:02:45-04:00
CEF BGH: High Yield Short Duration

2018-05-18T11:44:30-04:00
MeiraGTx Aims For $86 Million U.S. IPO

2018-05-18T10:09:17-04:00
Tracking John Paulson's Paulson & Co. Portfolio - Q1 2018 Update

2018-05-18T08:21:17-04:00
Investors bullish on biotechs after Trump drug pricing speech

2018-05-18T07:32:14-04:00
Valeant prices private offering of notes

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

348.71

Shares Float (M)

348.71

% Held by Insiders

2.00

% Held by Institutions

52.10

Shares Short (K)

21514

Shares Short Prior Month (K)

45180

Stock Financials

EPS

3.960

EPS Est. Current Year

3.890

EPS Est. Next Year

3.520

EPS Est. Next Quarter

0.930

Forward EPS

3.387

Book Value (p.s.)

1.570

PEG Ratio

-1.20

Profit Margin

-10.80

Operating Margin

6.36

Return on Assets (ttm)

-2.3

Return on Equity (ttm)

-22.0

Qtrly Rev. Growth

-10.0

Gross Profit (p.s.)

9.025

Sales Per Share

EBITDA (p.s.)

4.706

Qtrly Earnings Growth

Operating Cash Flow (M)

2290.00

Levered Free Cash Flow (M)

2920.00

atoplab.com

Valuation

P/E

5.57

P/E Growth Ratio

P/BV

14.06

P/S

309476160.00

P/CF

3.36

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2010-12-22

Ex-Dividend Date

2010-11-10

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.